The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2019

Filed:

Mar. 18, 2016
Applicants:

Universität Stuttgart, Stuttgart, DE;

Biontech Ag, Mainz, DE;

Inventors:

Ugur Sahin, Mainz, DE;

Roland Kontermann, Nürtingen, DE;

Klaus Pfizenmaier, Tiefenbronn, DE;

Martin Siegemund, Stuttgart, DE;

Meike Hutt, Stuttgart, DE;

Oliver Seifert, Stuttgart, DE;

Assignee:

UNIVERSITAT STUTTGART, Stuttgart, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/32 (2006.01); C07K 16/28 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); C07K 14/70575 (2013.01); C07K 16/32 (2013.01); C07K 2317/622 (2013.01); C07K 2317/626 (2013.01); C07K 2319/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/91 (2013.01);
Abstract

The present invention relates to a polypeptide comprising a component A with at least three tumor necrosis factor (TNF) homology domains of TNF-ligand family members (THD) in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof, and a component B comprising a dimerization domain. Further, the present invention relates to a polypeptide comprising at least three THDs in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof. Further, the invention relates to a nucleic acid comprising said polypeptides, a vector comprising said nucleic acid and a pharmaceutical composition comprising said polypeptides, or said nucleic acids or said vector. Further, the present invention relates to said polypeptides, said nucleic acid or said vector for the use as a medicament or for the use in the diagnosis, prophylaxis or treatment of hyperproliferative disorders and inflammatory disorders.


Find Patent Forward Citations

Loading…